Indefinite Delivery Contract SPE2DX15D3016

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award IDC, valued at up to $999,999,999.00, serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract has an ultimate completion date of December 31, 2025 and was awarded on April 27, 2015 with no set-aside requirements. The place of performance is Conshohocken, PA. The contract enables the DLA to efficiently procure essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

In addition to the IDC, the report provides details on numerous delivery orders issued under the contract for a wide variety of medical products, such as prescription drugs, vaccines, and medical devices. These delivery orders cover a broad spectrum of therapeutic areas and were awarded on a firm fixed price basis to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The delivery orders range in value from tens to hundreds of thousands of dollars and have ultimate completion dates in 2022, demonstrating the ongoing nature of the contract to fulfill the government's pharmaceutical and medical supply needs.